Wen-Xiu Xin (Wenxiu Xin)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Radical Prostatectomy

Nitric Oxide Synthase

Top Venues

Expert review of anticancer therapy

Cell biology international

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Meng-Fei Dai, Xin Wang, Wen-Xiu Xin, Si-Si Kong, Wei-Ben Xu, Hai-Ying Ding, Luo Fang
Safety and hematological toxicities of PARP inhibitors in patients with cancer: a systematic review of randomized controlled trials and a pharmacovigilance analysis. Expert review of anticancer therapy 24 (7) (2024)
Haiying Ding, Shujing Li, Xinglu Xu, Weiben Xu, Chaoneng He, Wen-Xiu Xin, Zha-Jun Zhan, Luo Fang
Cost-effectiveness analysis of rezvilutamide versus bicalutamide in the treatment of metastatic hormone-sensitive prostate cancer. BMJ open 14 (7) (2024)
Meng-Fei Dai, Xin Wang, Wen-Xiu Xin, Si-Si Kong, Wei-Ben Xu, Hai-Ying Ding, Luo Fang
Safety and hematological toxicities of PARP inhibitors in patients with cancer: a systematic review of randomized controlled trials and a pharmacovigilance analysis. Expert review of anticancer therapy (2024)
Haiying Ding, Shujing Li, Xinglu Xu, Weiben Xu, Chaoneng He, Wen-Xiu Xin, Zha-Jun Zhan, Luo Fang
Cost-effectiveness analysis of rezvilutamide versus bicalutamide in the treatment of metastatic hormone-sensitive prostate cancer. BMJ open 14 (7) (2024)
Meng-Fei Dai, Xin Wang, Wen-Xiu Xin, Si-Si Kong, Wei-Ben Xu, Hai-Ying Ding, Luo Fang
Safety and hematological toxicities of PARP inhibitors in patients with cancer: a systematic review of randomized controlled trials and a pharmacovigilance analysis. Expert review of anticancer therapy (2024)
Haiying Ding, Shujing Li, Xinglu Xu, Weiben Xu, Chaoneng He, Wen-Xiu Xin, Zha-Jun Zhan, Luo Fang
Cost-effectiveness analysis of rezvilutamide versus bicalutamide in the treatment of metastatic hormone-sensitive prostate cancer. BMJ open 14 (7) (2024)
Qilu Fang, Qinglin Li, Yajun Qi, Zongfu Pan, Tingting Feng, Wen-Xiu Xin
ASPM promotes migration and invasion of anaplastic thyroid carcinoma by stabilizing KIF11. Cell biology international (2023)
Junfeng Zhu, Haiying Ding, Like Zhong, Wen-Xiu Xin, Xiaojiao Yi, Luo Fang
Spectrum-Effect Relationship-Based Strategy Combined with Molecular Docking to Explore Bioactive Flavonoids from Sceptridium ternatum . Molecules (Basel, Switzerland) 27 (17) (2022)
Wen-Xiu Xin, Haiying Ding, Qilu Fang, Xiaowei Zheng, Ying-Hui Tong, Gaoqi Xu, Guonong Yang
Cost-effectiveness of pembrolizumab for treatment of platinum-resistant recurrent or metastatic head and neck squamous cell carcinoma in China: an economic analysis based on a randomised, open-label, phase III trial. BMJ open 10 (12) (2020)